Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Defining the role of post-mastectomy radiotherapy: the new evidence.
1996
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Akt kinases in breast cancer and the results of adjuvant therapy
2003
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
Mammographic Density and the Risk and Detection of Breast Cancer
2007 Standout
The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long-term follow-up results of a randomised trial
1992
Breast cancer
2016 Standout
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.
1995
A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
1996
Repression of interleukin‐6 gene expression by 17β‐estradiol:
1997
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Chemoprevention strategies for the control of cancer
1993
Combined Screening With Ultrasound and Mammography vs Mammography Alone in Women at Elevated Risk of Breast Cancer
2008 Standout
Breast Density as a Predictor of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
2000 Standout
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
1997 Standout
High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients.
1993
Postmastectomy radiotherapy in the management of operable breast cancer
1994
Does tamoxifen cause cancer in humans?
1998
Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
1994
Pathological prognostic factors in breast cancer
1999 Standout
Measuring inconsistency in meta-analyses
2003 Standout
Prognostic Significance of Tumor Cell Proliferation Analyzed in Fine Needle Aspirates from Primary Breast Cancer
2002
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Uterine fibroids
2001 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
1989
Male breast cancer
2006 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
The process of metastasisation for breast cancer
2003
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
2013
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
2005 Standout
The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen
1998 Standout
Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes.
1998
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
1994 Standout
Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy
2003
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Trends in Use of Adjuvant Multi-Agent Chemotherapy and Tamoxifen for Breast Cancer in the United States: 1975-1999
2002
Microenvironmental regulation of metastasis
2008 Standout
Breast cancer adjuvant therapy
1990
Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant Chemotherapy
1997 Standout
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
2006
A comparison of androgen status in patients with prostatic cancer treated with oral and/or parenteral estrogens or by orchidectomy
1989
Oestrogen Receptor Analysis of Paraffin Sections and Cytosol Samples of Primary Breast Cancer in Relation to Outcome After Adjuvant Tamoxifen Treatment
1996
Production and Actions of Estrogens
2002 Standout
Epidural anaesthesia and analgesia and outcome of major surgery: a randomised trial
2002 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen
2010
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial
2003
Endometrial cancer
1997
Extended adjuvant endocrine therapy in hormone-receptor positive early breast cancer: Current and future evidence
2015
Breast Tumor Characteristics as Predictors of Mammographic Detection: Comparison of Interval- and Screen-Detected Cancers
1999
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001--Testing for Early Lung Cancer Detection
2001
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Lymphatic Mapping and Sentinel Node Biopsy in the Patient With Breast Cancer
1996 Standout
Adjuvant Therapy for Breast Cancer: Practice Patterns of Community Physicians
2002
Clinical decision-making in early breast cancer.
1993
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma
1998
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
1992 Standout
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
2006
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.
1990
Process Development for a Large Scale Stereoselective Synthesis of (Z)-(1-Bromobut-1-ene-1,2-diyl)dibenzene, a Key Intermediate of a Selective Estrogen Receptor Modulator
2010
Tamoxifen Versus Control After Adjuvant, Risk-Adapted Chemotherapy in Postmenopausal, Receptor-Negative Patients With Breast Cancer: A Randomized Trial (GABG-IV D-93)—The German Adjuvant Breast Cancer Group
2005
Prognostic Significance of a Novel Hypoxia-Regulated Marker, Carbonic Anhydrase IX, in Invasive Breast Carcinoma
2001 StandoutNobel
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women
1996
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
2002 Standout
Tamoxifen for early breast cancer: an overview of the randomised trials
1998 Standout
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Preclinical Evidence for Therapeutic Efficacy of Selective Estrogen receptor Modulators for Uterine Leiomyoma
2000
Nonnuclear Actions of Estrogen
2002
Evolving concepts in the systemic adjuvant treatment of breast cancer.
1992
Endometrial Carcinoma
1996
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
2005 Standout
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
2005 Standout
Works of Anders Somell being referenced
The Stockholm trial on adjuvant tamoxifen in early breast cancer
1987
Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer
1990
Randomized Trial of Adjuvant Tamoxifen in Node Negative Postmenopausal Breast Cancer
1992
ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
1989
Analysis of interval breast carcinomas in a randomized screening trial in Stockholm
1987
Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials
1989
METABOLISM OF 3β-HYDROXY-Δ5- AND 3-OXO-Δ4-C19 AND C21 STEROIDS IN HUMAN LIVER MICROSOMES
1972